US federal backing for local start-up Phlow Corp. is generally seen as part of COVID-19-related "medicines nationalism" playing out as the US seeks to lower dependency on foreign nations to support its drug supply chain.
The collaborative effort, touted as a "defining moment and inflection point" for safeguarding the country from future public health threats, intends to bolster medicines security and provide a
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?